在宫癌中延迟呈现到治疗结束的决定因素
Dimpy Begum1, Karthik Chandra Bassetty2, Debabrata Barmon1
1Department of Gynaecological oncology, BBCI, Guwahati, Assam, India.
Scientific reports
|November 21, 2025
概括
宫癌诊断和治疗的延迟在印度东北部是显著的,缺乏意识和有限的查有助于延长患者的旅程. 提高公众知识和获得医疗保健的机会对于实现宫癌消除目标至关重要.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 宫癌仍然是一个重要的健康问题,特别是在资源较低的环境中.
- 及时诊断和治疗启动对于改善患者的治疗结果和实现消除目标至关重要.
研究的目的:
- 评估从症状出现到宫癌诊断和治疗完成的时间间隔.
- 确定导致患者治疗途径延迟的因素.
主要方法:
- 一项在印度东北部的三级癌症中心进行的前性观察研究.
- 分析了101名患有宫癌的患者的表现,诊断和治疗延迟情况.
- 使用单变量分析来识别相关因素.
主要成果:
- 平均延迟时间为60天 (呈现),7天 (诊断),28天 (开始治疗) 和56天 (完成治疗).
- 人们对症状的认识不足 (77%的人不知道异常出血是红旗) 和缺乏查是普遍存在的.
- 与延迟相关的因素包括年龄大于50岁,没有先前的妇科检查,意识不良,"骗子"咨询,对疾病的担忧,贫困和转诊高级成像.
结论:
- 印度东北部宫癌治疗途径存在重大延迟,原因是公众意识低,查机会有限.
- 解决这些延误需要加强公众宣传活动,改善诊断设施,以及更好地利用保险计划.
- 这些干预措施对于加速实现世界卫生组织2030年消除宫癌目标的进展至关重要.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.9K
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
10.2K
相关概念视频
Cancer Survival Analysis
633
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
633
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
